1. Home
  2. Downgrades
  3. This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Today

This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Today

2
0

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Deutsche Bank analyst Bryan Keane downgraded the rating on Accenture plc (NYSE:ACN) from Buy to Hold, while slashing the price target from $409 to $295. Accenture shares declined 0.2% to close at $306.95 on Tuesday. See how other analysts view this stock.
  • Stifel analyst Stephen Willey downgraded Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) from Buy to Hold and lowered the price target from $6 to $1.5. Bolt Biotherapeutics shares slipped …

Full story available on Benzinga.com

Visited 2 times, 1 visit(s) today